Feb 23, 2026

Feb 23, 2026

Premiere at Mary Jane 2025

Premiere at Mary Jane 2025

CannaCapital Group has announced the development of a new integrated cannabis clinic platform designed to connect patients, physicians, and pharmaceutical-grade supply chains within compliant medical frameworks.

CannaCapital Group has announced the development of a new integrated cannabis clinic platform designed to connect patients, physicians, and pharmaceutical-grade supply chains within compliant medical frameworks.

Zurich, Switzerland

CannaCapital Group today announced the expansion of its European distribution network, surpassing 4,000 compliant retail touchpoints across regulated markets. The milestone reflects the Group’s continued investment in vertically integrated infrastructure and its commitment to secure, high-quality market access for THC and CBD products.

Through strategic partnerships and strengthened logistics capabilities, the company has enhanced cross-border supply chain coordination while maintaining strict adherence to Swiss and EU regulatory frameworks. The expansion includes increased pharmacy placements, specialty retail partnerships, and B2B distribution agreements across Germany, France, and neighboring EU markets.

“Our priority is to deliver consistency, compliance, and operational excellence at scale,” said a spokesperson for CannaCapital Group. “Expanding our distribution footprint allows us to better serve patients, partners, and consumers within regulated environments.”

The company indicated that further network development initiatives are underway, with a focus on reinforcing traceability systems, quality management protocols, and sustainable logistics solutions throughout 2026.

Other releases

Other releases

Your Gateway to Europe’s Medical Cannabis Market

Your Gateway to Europe’s Medical Cannabis Market

The licensed route from source to pharmacy across Germany and the EU.

The licensed route from source to pharmacy across Germany and the EU.

Canna Capital Group AG

Bahnhofstrasse 3
CH-8808 Pfäffikon

+41(0)6 25 21 01 43

© Canna Capital Group AG

a web by mimosa